Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
NACRES:
NA.51
UNSPSC Code:
41105324
description
Powered by Eupheria Biotech
Quality Level
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
CTCATCAGGAAGCTGGAAGGAAGCACTGAAGATTGAGGGCCCCGCCTCATCAGACACCTGCTCTCTGACACACAGCTCTGGGTGCACACTCAGAGACAGAGTTCTGGATCACGTGGGCCCAGTGCAGTTCAAATAAAACCAGCCTCAGCGGAATCCTAGAAAATGTTAGTCGTGAGTCCCCAGAGCCACTGCATTCATCCCATATCCTTCTGTGCGTTCAGATG
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Gene Information
human ... GLT1D1(144423)
General description
MISSION esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
Storage Class
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Xiaoxia Liu et al.
Molecular oncology, 14(5), 1028-1044 (2020-03-12)
B-cell non-Hodgkin's lymphoma (NHL) is a class of heterogeneous diseases with variable clinical outcomes. Immunosuppression is particularly common in the subtypes of lymphoma with poor prognosis, but the underlying mechanism remains unclear. Using a RT-PCR array analysis, we have identified
Global Trade Item Number
| SKU | GTIN |
|---|---|
| EHU099631-20UG | 04061828590346 |
| EHU099631-50UG | 04061828366255 |